Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence.

Accurate markers for prostate cancer (PC) risk stratification could aid decision-making for initial management strategies. The 4Kscore has an undefined role in predicting outcomes after radical prostatectomy (RP).